©The Author(s) 2025.
World J Gastrointest Surg. Nov 27, 2025; 17(11): 109989
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.109989
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.109989
Table 3 Perioperative morbidity and mortality
| Ref. | 30-day mortality | 90-day mortality | Postoperative complications |
| Safiejko et al[6] | |||
| RLR | 0.5% (2/372); RLR vs LLR: OR = 1.23, 95%CI: 0.32-4.83 | 0.0% (0/178); RLR vs LLR: OR = 1.78, 95%CI: 0.23-14.03 | 21.9% (106/482); RLR vs LLR: OR = 1.04, 95%CI: 0.81-1.32 |
| LLR | 0.7% (13/1931) | 1.3% (10/789) | 22.4% (404/1806) |
| Machairas et al[7] | 0% (0/29) | 0% (0/29) | 37.9% (11/29) |
| Mkabaah et al[9] | |||
| RLR | 0.7% (2/268); RLR vs OLR: OR = 1.24, 95%CI: 0.24-6.36 | 0.6% (1/179); RLR vs OLR: OR = 0.45, 95%CI: 0.07-3.03 | 23.6% (45/191); RLR vs OLR: OR = 0.52, 95%CI: 0.32-0.86 |
| LLR | 0.3% (5/1530); LLR vs OLR: OR = 1.01, 95%CI: 0.29-3.58 | 0.3% (1/292); LLR vs OLR: OR = 0.64, 95%CI: 0.08-5.24 | 16.6% (113/678); LLR vs OLR: OR = 0.50, 95%CI: 0.37-0.68 |
| OLR | 0.7% (6/862) | 1.4% (4/296) | 26.4% (262/992) |
| Ho et al[12] | 0% (0/217) | 0% (0/217) | 20.3% (48/236) |
| McGuirk et al[13] | 0% (0/28) | 2.8% (1/28) | 28.6% (8/28) |
- Citation: Ardila CM, Zuluaga-Gómez M, González-Arroyave D. Robotic liver surgery for metastatic disease: A review of safety, feasibility, and outcomes. World J Gastrointest Surg 2025; 17(11): 109989
- URL: https://www.wjgnet.com/1948-9366/full/v17/i11/109989.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i11.109989